Proactiveinvestors United Kingdom RNS press releases https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom RNS press releases RSS feed en Tue, 21 May 2019 20:28:07 +0100 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[RNS press release - Appointment of Joint Broker ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190508070005_14065690 Wed, 08 May 2019 07:00:05 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190508070005_14065690 <![CDATA[RNS press release - Investor presentation ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190502070005_14060251 Thu, 02 May 2019 07:00:05 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190502070005_14060251 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190501115845_14059480 Wed, 01 May 2019 11:58:45 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190501115845_14059480 <![CDATA[RNS press release - 2018 Annual Report and 2019 AGM Notice ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190430070004_14056240 Tue, 30 Apr 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190430070004_14056240 <![CDATA[RNS press release - PDMR Acquisition of Shares ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190426180526_14054363 Fri, 26 Apr 2019 18:05:26 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190426180526_14054363 <![CDATA[RNS press release - Major extension to approval in Switzerland ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190424070004_14049216 Wed, 24 Apr 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190424070004_14049216 <![CDATA[RNS press release - Grant of share options ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190417170643_14045285 Wed, 17 Apr 2019 17:06:43 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190417170643_14045285 <![CDATA[RNS press release - PDMR Acquisition of Shares and Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190417170146_14045280 Wed, 17 Apr 2019 17:01:46 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190417170146_14045280 <![CDATA[RNS press release - PDMR Acquisition of Shares ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190417165642_14045271 Wed, 17 Apr 2019 16:56:42 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190417165642_14045271 <![CDATA[RNS press release - Holding(s) in Company ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190411164013_14038293 Thu, 11 Apr 2019 16:40:13 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190411164013_14038293 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190408154250_14033071 Mon, 08 Apr 2019 15:42:50 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190408154250_14033071 <![CDATA[RNS press release - Final Results ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190403070004_14026364 Wed, 03 Apr 2019 07:00:04 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190403070004_14026364 <![CDATA[RNS press release - Additional Listing ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190401174459_14024357 Mon, 01 Apr 2019 17:44:59 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190401174459_14024357 <![CDATA[RNS press release - Change of Adviser ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190401120001_14023649 Mon, 01 Apr 2019 12:00:01 +0100 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190401120001_14023649 <![CDATA[RNS press release - Notice of Results ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190327070006_14016929 Wed, 27 Mar 2019 07:00:06 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190327070006_14016929 <![CDATA[RNS press release - Positive decision on Feraccru®'s process patent ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190314153122_14002924 Thu, 14 Mar 2019 15:31:22 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190314153122_14002924 <![CDATA[RNS press release - Positive results for Feraccru® in AEGIS-H2H study ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190304070007_13988235 Mon, 04 Mar 2019 07:00:07 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190304070007_13988235 <![CDATA[RNS press release - Positive results of AEGIS-CKD study ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190129070007_13949532 Tue, 29 Jan 2019 07:00:07 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190129070007_13949532 <![CDATA[RNS press release - Business and trading update ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190124070005_13944846 Thu, 24 Jan 2019 07:00:05 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190124070005_13944846 <![CDATA[RNS press release - Investor presentations ]]> https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190123101939_13944165 Wed, 23 Jan 2019 10:19:39 +0000 https://www.proactiveinvestors.co.uk/LON:STX/Shield-Therapeutics-PLC/rns/LSE20190123101939_13944165